GCIA
KIN

Gabelli & Co Investment Advisers’s Kindred Biosciences, Inc. KIN Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-164,685
Closed -$1.51M – 566
2021
Q2 		$1.51M Buy
+164,685
New +$958K 0.17% 86

Other funds holding KIN

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Gabelli & Co Investment Advisers's KIN Position: Q3 2021 in Review

Gabelli & Co Investment Advisers sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 164,685 shares — an estimated $1.51M sold.

Gabelli & Co Investment Advisers first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $1.51M in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • Gabelli & Co Investment Advisers reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 164,685 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $1.51M.
  • Gabelli & Co Investment Advisers first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Kindred Biosciences, Inc. position peaked at $1.51M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.